Target intelligence / Profile preview

Plasmodium blood-stage parasite

Molecular classification
Other (multicellular eukaryotic parasite stage, not a single molecule, protein, or canonical molecular target class)
01

Overview

Blood-stage Plasmodium parasites are the asexual developmental forms of Plasmodium that invade and replicate within human red blood cells. These stages (ring, trophozoite, and schizont) are responsible for the clinical manifestations of malaria, including fever, anemia, and, in severe cases, organ failure. The parasites digest host hemoglobin and undergo mitotic replication (schizogony), releasing merozoites that reinvade new red cells. All current frontline antimalarial drugs are designed to kill or inhibit these blood stages, which are essential for malaria pathogenesis and transmission. These stages are not a single molecular entity but represent a critical therapeutic target category in malaria control and eradication efforts.

Other names
Blood-stage Plasmodiumasexual blood-stage malaria parasiteintraerythrocytic stage Plasmodiumring stagetrophozoite stageschizont stage
02

Mechanism of action

Inhibition of heme detoxification (e.g., chloroquine); Generation of reactive oxygen species (e.g., artemisinins); Inhibition of mitochondrial electron transport (e.g., atovaquone); Inhibition of folate metabolism (e.g., pyrimethamine, sulfadoxine); Direct disruption of parasite protein synthesis or transport (e.g., doxycycline, tetracyclines)

03

Biological functions

Red blood cell invasionAsexual parasite replication (schizogony)Hemoglobin digestionProduction of disease symptoms (malaria pathology)
04

Disease associations

Infection (malaria)Disease progression and morbidity (all clinical manifestations of malaria are caused by these stages)
05

Safety considerations

Rapid emergence of drug resistanceHigh potential for severe disease and complicationsParasite persistence and recrudescenceOverlapping toxicity of antimalarials (cardiotoxicity, hemolysis, QT prolongation as drug class effects)
06

Interacting drugs

Artemisinin and derivatives (dihydroartemisinin, artesunate)

10 more in the full profile.

07

Biomarkers

Parasite DNA/RNA (detected by PCR, rapid diagnostic tests)Parasitemia (number of parasites per μL blood by microscopy)HRP2 (Plasmodium falciparum histidine-rich protein 2)LDH (Plasmodium lactate dehydrogenase)

Beyond the preview

Go deeper on Plasmodium blood-stage parasite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium blood-stage parasite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call